Nektar Therapeutics Increase (Decrease) in Other Accrued Liabilities
Nektar Therapeutics (NKTR) reported Increase (Decrease) in Other Accrued Liabilities of $37.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-08-14
- Nektar Therapeutics increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was -$2.29M, a 184.00% decline year-over-year.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was $2.33M, a 91.44% increase year-over-year.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was -$2.72M.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was -$7.00M, a 206.92% decline year-over-year.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for fiscal 2025 was -$5.79M, a 153.90% decline from fiscal 2024.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for fiscal 2024 was $10.73M.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for fiscal 2023 was -$17.26M.
- Nektar Therapeutics increase (decrease) in other accrued liabilities for fiscal 2022 was -$12.73M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $37.00K 10-Q · filed 2026-08-14 | -$2.69M derived: sum of 3 quarters · filed 2026-08-14 | -$9.69M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $2.33M 10-Q · filed 2026-05-08 | -$397.00K derived: sum of 2 quarters · filed 2026-05-08 | -$7.40M derived: sum of 3 quarters · filed 2026-05-08 | -$4.67M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$9.72M derived: sum of 2 quarters · filed 2026-03-13 | -$7.00M derived: sum of 3 quarters · filed 2026-08-14 | -$5.79M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.28M derived: sum of 2 quarters · filed 2026-08-14 | -$3.06M 10-Q · filed 2025-11-07 | -$9.65M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $3.94M 10-Q · filed 2026-08-14 | -$2.64M derived: sum of 3 quarters · filed 2026-08-14 | $3.90M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $1.22M 10-Q · filed 2026-05-08 | -$5.37M derived: sum of 2 quarters · filed 2026-05-08 | $1.18M derived: sum of 3 quarters · filed 2026-05-08 | $10.13M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$6.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$35.00K derived: sum of 2 quarters · filed 2026-03-13 | $8.91M derived: sum of 3 quarters · filed 2026-03-13 | $10.73M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $6.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $15.50M derived: sum of 2 quarters · filed 2025-11-07 | $17.32M 10-Q · filed 2025-11-07 | $17.33M 10-Q · filed 2024-11-08 | $7.57M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $10.77M 10-Q · filed 2025-08-08 | $10.75M 10-Q · filed 2024-08-09 | $1.02M derived: sum of 3 quarters · filed 2025-08-08 | $1.43M derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | $1.82M 10-Q · filed 2025-05-09 | $1.86M 10-Q · filed 2024-05-10 | -$7.93M derived: sum of 2 quarters · filed 2025-05-09 | -$7.52M derived: sum of 3 quarters · filed 2025-05-09 | -$17.09M derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$9.34M derived: sum of 2 quarters · filed 2025-03-14 | -$18.90M derived: sum of 3 quarters · filed 2025-03-14 | -$17.26M 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | $412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$9.16M derived: sum of 2 quarters · filed 2024-11-08 | -$7.52M 10-Q · filed 2024-11-08 | -$21.85M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | -$9.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$7.93M 10-Q · filed 2024-08-09 | -$22.27M derived: sum of 3 quarters · filed 2024-08-09 | -$33.73M derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $1.64M 10-Q · filed 2024-05-10 | -$12.70M derived: sum of 2 quarters · filed 2024-05-10 | -$24.16M derived: sum of 3 quarters · filed 2024-05-10 | -$25.26M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | -$14.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$25.80M derived: sum of 2 quarters · filed 2023-11-08 | -$26.90M derived: sum of 3 quarters · filed 2023-11-08 | -$12.73M 10-K · filed 2023-02-28 | ||||
| 2022-09-30 | -$11.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$12.56M derived: sum of 2 quarters · filed 2023-11-08 | $1.60M 10-Q · filed 2023-11-08 | -$7.05M 10-Q · filed 2022-11-04 | -$17.48M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $13.07M 10-Q · filed 2023-08-09 | -$1.52M 10-Q · filed 2022-08-05 | -$6.01M derived: sum of 3 quarters · filed 2023-08-09 | -$6.36M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $14.17M 10-Q · filed 2023-05-10 | $7.25M 10-Q · filed 2022-05-06 | -$4.92M derived: sum of 2 quarters · filed 2023-05-10 | -$5.26M derived: sum of 3 quarters · filed 2023-05-10 | -$1.41M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$19.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$19.42M derived: sum of 2 quarters · filed 2023-02-28 | -$15.57M derived: sum of 3 quarters · filed 2023-02-28 | -$23.52M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | -$341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $3.51M derived: sum of 2 quarters · filed 2022-11-04 | -$4.44M 10-Q · filed 2022-11-04 | -$3.84M 10-Q · filed 2021-11-05 | -$5.14M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$4.10M 10-Q · filed 2022-08-05 | -$3.50M 10-Q · filed 2021-08-06 | -$4.80M derived: sum of 3 quarters · filed 2023-02-28 | -$4.41M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | -$7.95M 10-Q · filed 2022-05-06 | -$7.34M 10-Q · filed 2021-05-07 | -$8.65M derived: sum of 2 quarters · filed 2023-02-28 | -$8.26M derived: sum of 3 quarters · filed 2023-02-28 | -$6.79M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | -$696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$308.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.16M derived: sum of 3 quarters · filed 2023-02-28 | $8.64M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $1.86M derived: sum of 2 quarters · filed 2021-11-05 | $9.34M 10-Q · filed 2021-11-05 | $3.29M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $8.95M 10-Q · filed 2021-08-06 | $2.90M derived: sum of 3 quarters · filed 2022-03-01 | -$2.49M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $7.48M 10-Q · filed 2021-05-07 | $7.72M 10-Q · filed 2020-05-08 | $1.43M derived: sum of 2 quarters · filed 2022-03-01 | -$3.96M derived: sum of 3 quarters · filed 2022-03-01 | $11.06M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$11.45M derived: sum of 2 quarters · filed 2022-03-01 | $3.58M derived: sum of 3 quarters · filed 2022-03-01 | $4.35M 10-K · filed 2022-03-01 | $3.82M 10-K · filed 2020-02-28 | |||
| 2019-09-30 | -$5.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $9.63M derived: sum of 2 quarters · filed 2020-11-06 | $10.40M 10-Q · filed 2020-11-06 | $10.02M 10-Q · filed 2019-11-07 | $15.29M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-06-30 | $15.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $15.79M 10-Q · filed 2020-08-07 | $15.51M 10-Q · filed 2019-08-09 | $20.68M derived: sum of 3 quarters · filed 2021-02-26 | $31.87M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-03-31 | $774.00K 10-Q · filed 2020-05-08 | $5.66M derived: sum of 2 quarters · filed 2021-02-26 | $16.85M derived: sum of 3 quarters · filed 2021-02-26 | $21.44M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $16.07M derived: sum of 2 quarters · filed 2021-02-26 | $20.67M derived: sum of 3 quarters · filed 2021-02-26 | $31.49M 10-K · filed 2021-02-26 | $27.95M 10-K · filed 2019-03-01 | |||
| 2018-09-30 | $11.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $15.78M derived: sum of 2 quarters · filed 2019-11-07 | $26.60M 10-Q · filed 2019-11-07 | $14.10M 10-Q · filed 2018-11-08 | $28.91M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | $4.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $15.42M 10-Q · filed 2019-08-09 | $4.90M 10-Q · filed 2018-08-09 | $17.72M derived: sum of 3 quarters · filed 2020-02-28 | $20.31M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | $10.83M 10-Q · filed 2019-05-09 | $605.00K 10-Q · filed 2018-05-10 | $13.13M derived: sum of 2 quarters · filed 2020-02-28 | $15.71M derived: sum of 3 quarters · filed 2020-02-28 | $16.30M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $4.89M derived: sum of 2 quarters · filed 2020-02-28 | $5.48M derived: sum of 3 quarters · filed 2020-02-28 | $7.28M 10-K · filed 2020-02-28 | $5.77M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.17M derived: sum of 2 quarters · filed 2018-11-08 | $4.97M 10-Q · filed 2018-11-08 | $2.51M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.39M 10-Q · filed 2018-08-09 | -$69.00K derived: sum of 3 quarters · filed 2019-03-01 | -$514.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $1.80M 10-Q · filed 2018-05-10 | -$659.00K derived: sum of 2 quarters · filed 2019-03-01 | -$1.10M derived: sum of 3 quarters · filed 2019-03-01 | -$449.00K derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | -$2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$2.90M derived: sum of 2 quarters · filed 2019-03-01 | -$2.25M derived: sum of 3 quarters · filed 2019-03-01 | -$71.00K 10-K · filed 2019-03-01 | $191.00K 10-K · filed 2017-03-01 | |||
| 2016-09-30 | -$445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $210.00K derived: sum of 2 quarters · filed 2017-11-08 | $2.39M 10-Q · filed 2017-11-08 | -$841.00K derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $655.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.83M 10-Q · filed 2017-08-09 | -$396.00K derived: sum of 3 quarters · filed 2018-03-01 | -$1.31M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $2.18M 10-Q · filed 2017-05-10 | -$1.05M derived: sum of 2 quarters · filed 2018-03-01 | -$1.96M derived: sum of 3 quarters · filed 2018-03-01 | -$1.91M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | -$3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$4.14M derived: sum of 2 quarters · filed 2018-03-01 | -$4.09M derived: sum of 3 quarters · filed 2018-03-01 | -$2.28M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | -$910.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$862.00K derived: sum of 2 quarters · filed 2016-11-04 | $949.00K 10-Q · filed 2016-11-04 | -$445.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.86M 10-Q · filed 2016-08-04 | $465.00K derived: sum of 3 quarters · filed 2017-03-01 | $2.45M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $1.81M 10-Q · filed 2016-05-04 | $417.00K derived: sum of 2 quarters · filed 2017-03-01 | $2.40M derived: sum of 3 quarters · filed 2017-03-01 | |||||
| 2014-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $587.00K derived: sum of 2 quarters · filed 2017-03-01 | $273.00K 10-K · filed 2017-03-01 | |||||
| 2014-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.67M 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | -$314.00K 10-Q · filed 2015-08-06 | |||||||
| 2013-12-31 | -$1.92M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |